Ginsenoside F2

Ginsenoside F2, a metabolite from Ginsenoside Rb1, induces apoptosis accompanied by protective autophagy in breast cancer stem cells[1].

Product Specifications

CAS Number

[62025-49-4]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H332, H335

Target

Apoptosis; Autophagy; Endogenous Metabolite

Type

Natural Products

Related Pathways

Apoptosis; Autophagy; Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ginsenoside-f2.html

Concentration

10mM

Purity

99.95

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

C[C@@]([C@@]12C)(CC[C@@]3([H])C4(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@@](CC/C=C(C)/C)(C)O[C@@H]([C@@H]([C@@H](O)[C@@H]5O)O)O[C@@H]5CO)([H])CC2)([H])[C@]3(CC[C@@H]4O[C@]([C@@H]([C@@H](O)[C@@H]6O)O)([H])O[C@@H]6CO)C

Molecular Formula

C42H72O13

Molecular Weight

785.01

Precautions

H302, H315, H319, H332, H335

References & Citations

[1]Mai TT, et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett. 2012 Aug 28;321 (2) :144-53.